- call +1-201-465-4211
- email sales@mrinsights.biz
Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.
Scope of the Report:
The global Orthopaedic Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Orthopaedic Oncology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Orthopaedic Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Orthopaedic Oncology market by product type and applications/end industries.
Market Segment by Companies, this report covers
Stryker Corporation
Amgen Inc.
Creganna Medical Group
Accentus Inc.
Canon Medical Systems
Siemens Healthineers
MD Anderson Cancer Center
F. Hoffmann-La Roche Ltd.
Novartis AG
Sanofi S.A.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy
Market Segment by Applications, can be divided into
Hospitals
Research Laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Orthopaedic Oncology Market Overview
1.1 Product Overview and Scope of Orthopaedic Oncology
1.2 Classification of Orthopaedic Oncology by Types
1.2.1 Global Orthopaedic Oncology Revenue Comparison by Types (2017-2023)
1.2.2 Global Orthopaedic Oncology Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.2.6 Targeted Therapy
1.3 Global Orthopaedic Oncology Market by Application
1.3.1 Global Orthopaedic Oncology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Global Orthopaedic Oncology Market by Regions
1.4.1 Global Orthopaedic Oncology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Orthopaedic Oncology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Orthopaedic Oncology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Orthopaedic Oncology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Orthopaedic Oncology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Orthopaedic Oncology Status and Prospect (2013-2023)
1.5 Global Market Size of Orthopaedic Oncology (2013-2023)
2 Manufacturers Profiles
2.1 Stryker Corporation
2.1.1 Business Overview
2.1.2 Orthopaedic Oncology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Stryker Corporation Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen Inc.
2.2.1 Business Overview
2.2.2 Orthopaedic Oncology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Creganna Medical Group
2.3.1 Business Overview
2.3.2 Orthopaedic Oncology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Creganna Medical Group Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Accentus Inc.
2.4.1 Business Overview
2.4.2 Orthopaedic Oncology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Accentus Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Canon Medical Systems
2.5.1 Business Overview
2.5.2 Orthopaedic Oncology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Canon Medical Systems Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Siemens Healthineers
2.6.1 Business Overview
2.6.2 Orthopaedic Oncology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Siemens Healthineers Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.7 MD Anderson Cancer Center
2.7.1 Business Overview
2.7.2 Orthopaedic Oncology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MD Anderson Cancer Center Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.8 F. Hoffmann-La Roche Ltd.
2.8.1 Business Overview
2.8.2 Orthopaedic Oncology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 F. Hoffmann-La Roche Ltd. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis AG
2.9.1 Business Overview
2.9.2 Orthopaedic Oncology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis AG Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi S.A.
2.10.1 Business Overview
2.10.2 Orthopaedic Oncology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi S.A. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Orthopaedic Oncology Market Competition, by Players
3.1 Global Orthopaedic Oncology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Orthopaedic Oncology Players Market Share
3.2.2 Top 10 Orthopaedic Oncology Players Market Share
3.3 Market Competition Trend
4 Global Orthopaedic Oncology Market Size by Regions
4.1 Global Orthopaedic Oncology Revenue and Market Share by Regions
4.2 North America Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
4.3 Europe Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
4.5 South America Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
5 North America Orthopaedic Oncology Revenue by Countries
5.1 North America Orthopaedic Oncology Revenue by Countries (2013-2018)
5.2 USA Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
5.3 Canada Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
5.4 Mexico Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
6 Europe Orthopaedic Oncology Revenue by Countries
6.1 Europe Orthopaedic Oncology Revenue by Countries (2013-2018)
6.2 Germany Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
6.3 UK Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
6.4 France Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
6.5 Russia Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
6.6 Italy Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Orthopaedic Oncology Revenue by Countries
7.1 Asia-Pacific Orthopaedic Oncology Revenue by Countries (2013-2018)
7.2 China Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
7.3 Japan Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
7.4 Korea Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
7.5 India Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
8 South America Orthopaedic Oncology Revenue by Countries
8.1 South America Orthopaedic Oncology Revenue by Countries (2013-2018)
8.2 Brazil Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
8.3 Argentina Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
8.4 Colombia Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Orthopaedic Oncology by Countries
9.1 Middle East and Africa Orthopaedic Oncology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
9.3 UAE Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
9.4 Egypt Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
9.6 South Africa Orthopaedic Oncology Revenue and Growth Rate (2013-2018)
10 Global Orthopaedic Oncology Market Segment by Type
10.1 Global Orthopaedic Oncology Revenue and Market Share by Type (2013-2018)
10.2 Global Orthopaedic Oncology Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Chemotherapy Revenue Growth Rate (2013-2023)
10.5 Radiation Therapy Revenue Growth Rate (2013-2023)
10.6 Targeted Therapy Revenue Growth Rate (2013-2023)
11 Global Orthopaedic Oncology Market Segment by Application
11.1 Global Orthopaedic Oncology Revenue Market Share by Application (2013-2018)
11.2 Orthopaedic Oncology Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Research Laboratories Revenue Growth (2013-2018)
12 Global Orthopaedic Oncology Market Size Forecast (2018-2023)
12.1 Global Orthopaedic Oncology Market Size Forecast (2018-2023)
12.2 Global Orthopaedic Oncology Market Forecast by Regions (2018-2023)
12.3 North America Orthopaedic Oncology Revenue Market Forecast (2018-2023)
12.4 Europe Orthopaedic Oncology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Orthopaedic Oncology Revenue Market Forecast (2018-2023)
12.6 South America Orthopaedic Oncology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Orthopaedic Oncology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Orthopaedic Oncology Picture
Table Product Specifications of Orthopaedic Oncology
Table Global Orthopaedic Oncology and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
